Latest filing published 03 Nov 2023 for Tryp Therapeutics Inc., €55k.
No signal scores available.
This profile gathers the share dealings of Peter Robert Molloy in Tryp Therapeutics Inc. Over a trading history stretching from 30 September 2020 to 30 October 2023, the count stands at 7 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 3 November 2023 came the latest disclosure, an option exercise for €55k in Tryp Therapeutics Inc. Filings reach the SEDI feed a median of 4 days after the trade. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations